Market Research Report
US Market Report Suite for Cardiac Surgery and Heart Valve Devices 2018 - MedSuite
|Published by||iData Research Inc.||Product code||601907|
|Published||Content info||417 Pages
Delivery time: 1-2 business days
|US Market Report Suite for Cardiac Surgery and Heart Valve Devices 2018 - MedSuite|
|Published: October 1, 2017||Content info: 417 Pages||
The U.S. market for cardiac surgery and heart valve devices includes tissue heart valves, mechanical heart valves, annuloplasty repair devices, transcatheter heart valve repair (THVR) devices, transcatheter heart valve replacement (THVI) devices, on-pump coronary artery bypass (ONCAB) devices, off-pump coronary artery bypass (OPCAB) devices, endoscopic vessel harvesting (EVH) devices, anastomosis assist devices (AADs), transmyocardial revascularization (TMR) devices, ventricular assist devices (VADs), intra-aortic balloon pumps, artificial heart replacement devices, patent foramen ovale (PFO), atrial septal defect (ASD) devices, ventricular septal defect (VSD) devices and left atrial appendage (LAA) devices.
General Report Contents
Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
Market Drivers & Limiters for each chapter segment
Competitive Analysis for each chapter segment
Section on recent mergers & acquisitions
The U.S. market for cardiac surgery and heart valve devices is being driven by technological advances in minimally invasive treatment options and ventricular support. Growth in the transcatheter aortic valve implantation device, transcatheter mitral valve repair device and left atrial appendage closure device segments form the core of the growth derived from improvements in minimally invasive treatment options.